Frequency, pattern and severity of nail changes in psoriasis determined By Nail Psoriasis Severity Index
DOI:
https://doi.org/10.66344/jpad.v36i2.3400Keywords:
Psoriasis, Nail Changes, Nail Psoriasis Severity Index ScaleAbstract
Background Psoriasis and nail disease are linked to discomfort, loss of function, deformity, and mental anguish.
Objective To determine the frequency, pattern and severity of nail changes in psoriasis.
Methods It is a descriptive cross sectional study that was held at OPD Department of dermatology, Jinnah Hospital-Lahore, Pakistan that enrolled 135 patients. Target Nail version of the nail psoriasis severity index scale was used to describe nail changes in which presence or absence of certain parameters were assessed clinically by magnifying glass. Each nail was given a score for nail matrix psoriasis from 0-32 included in Nail Psoriasis Severity Index (NAPSI), in that quadrant of nail. All the data was processed by SPSS v26.0. Frequency and percentages were used for categorical parameters. Chi square test was applied in which P value <.05 was considered significant.
Results Nail changes were observed in 81 patients (60.0%). Among nail changes pitting was most common. Severity of nail changes determined by NAPSI score was noted as mild in 76 patients (93.8%) and moderate in 5 patients (6.22%).
Conclusion We concluded that almost 60% patients with psoriasis had nail alterations, with pitting and subungual hyperkeratosis being the most prevalent.
References
1. Ahmad A. A critical review of Daus-Sadaf (Psoriasis): Unani & modern perspectives. Int J Creat Res Thoug. 2020;8(7):4570-82.
2. Menter A, Cordoro KM, Davis DM, Kroshinsky D, Paller AS, Armstrong AW, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161-201.
3. Liu R, Candela BM, English JC. Nail Psoriasis and Psoriatic Arthritis for the Dermatologist. J Dermatol Skin Sci. 2020;2(1):17-21.
4. Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: A review of the literature. An Bras Dermatol. 2019;89(2):312-7.
5. Debra K. Shari R. Optimal diagnosis and management of common nail disorders. Ann Med. 2022;54(1):694-71.
6. Arora S, Paul D, Kumar R, Bhatnagar A, Arora G, Mech S, et al. Study of Nail Psoriasis and Dermoscopic Correlation with Dermoscopic and Modified Dermoscopic Nail Psoriasis Severity Indexes (dNAPSI and dmNAPSI). Dermatol Pract Concept. 2022;12(1):e2022010.
7. Jendoubi F, Ben I, Rabhi F, Doss N, Mrabet A, Jaber K et.al,. Nail Involvement in Psoriatic Patients and Association with Onychomycosis: Results from a Cross-Sectional Study Performed in a Military Hospital in Tunisia. Skin Appendage Disord. 2019;5(5):299-303.
8. Grover C, Saha S, Pandhi D. Nail changes in COVID-19: A cross sectional study from India. Indian Dermatol Online J. 2022;13(3):326.
9. Bansal N, Chavan R, Belgaumkar V. Clinico-etiological Study of Nail Disorders at a Tertiary Care Center in Maharashtra, India. J Skin Stem Cell. 2021;8(3):e119437.
10. Liluashvili S, Kituashvili T. Dermatology Life Quality Index and disease coping strategiesin psoriasis patients. Postepy Dermatol Alergol. 2019;36(4):419-24.
11. Mease PJ, Liu M, Rebello S, McLean RR, Dube B, Glynn M, et al. Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol.2021;48(4):520-6.
12. Klaassen KM, van de Kerkhof PC, Pasch MC. Nail psoriasis: a questionnaire-based survey. Br J Dermatol. 2013;169(2):314-9.
13. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1-27.
14. Orizzo M, Tosti A. Nail psoriasis: an updated review of current concepts and management. Expert Rev Clin Immunol. 2023;19(9):1091-1100.
15. Kaur I, Handa S, Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol. 1997;24(4):230-34.
16. Brazzelli V, Carugno A, Alborghetti A, et al. Prevalence, severity and clinical features of nail psoriasis in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2012;26(9):1118-23.
17. Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP. Nail disease in psoriatic arthritis: Clinically important, potentially treatable and often overlooked. Rheumatology (Oxford). 2004;43(6):790-94.
18. Armesto S, Esteve A, Coto-Segura P, Drake M, Galache C, Santos-Juanes J. Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients. Actas Dermosifiliogr. 2011;102(5):365-72.
19. Castellanos-González M, Sánchez J, Vázquez-Herrera NE, et al. Nail involvement as a predictor of psoriatic arthritis. Dermatol Ther. 2022;35(2):e15291.
20. Tan ES, Chong WS, Tey HL. Nail psoriasis: a review. Am J Clin Dermatol. 2012;13(6):375-88.
21. De Berker D. Clinical practice. Nail psoriasis. N Engl J Med. 2009;360(7):720-28.
22. Kyriakou A, Patsatsi A, Sotiriadis D. Nail psoriasis: a review of treatment options. Drugs. 2016;76(7):675-705.
23. Rachadi H, Chiheb S. Dermoscopic features of nail psoriasis: a systematic review. Int J Dermatol. 2024;63(8):1013-19.
24. Agache M, Popescu CC, Enache L, Dumitrescu B, Codreanu C. Nail ultrasound in psoriasis and psoriatic arthritis: a narrative review. Diagnostics (Basel). 2023;13(13):2236.
25. Khan M, Wallace CE, Ahmed F, Rahman SM, Memon N, Haque A. Assessing comparative efficacy of biologics for the treatment of psoriasis with nail involvement: a systematic review. J Psoriasis Psoriatic Arthritis. 2024;9(2):61-8.
26. Horikawa H, Tanese K, Nonaka N, Seita J, Amagai M, Saito M, et al. Reliable and easy-to-use calculating tool for the Nail Psoriasis Severity Index using deep learning. NPJ Syst Biol Appl. 2024;10:130.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sajida Kousar, Rabia Mukhtar, Bushra Bashir, Samia Aslam, Ghazala Butt, Mohammad Jahangir
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
